Hers vs TMates: Wegovy vs Compounded Semaglutide Options
Hers vs TMates is a choice between FDA-approved brand-name GLP-1s and a flat-rate compounded semaglutide program. Early verdict: choose Hers if you want brand-name Wegovy® and no compounded medications; choose TMates if you prioritize a flat $199/month price with 24/7 U.S. doctor access.
See Hers’ Wegovy® plans from $149/mo
Key differences at a glance: price, medication type, and access
Direct comparison shows three decisive distinctions: Hers markets FDA-approved Wegovy® (brand-name semaglutide) with pricing starting at $149/mo and membership requirements, while TMates offers clinically dosed compounded semaglutide at a flat $199/month with no step-up fees. TMates highlights 24/7 access to U.S.-based doctors and coverage in all 50 states; Hers notes availability is not in all 50 states and requires an active membership for medication.
Medication type and regulatory notes
Hers provides FDA-approved Wegovy®, explicitly stating it is not a compounded product. TMates supplies compounded semaglutide formulated in U.S. facilities and notes compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Both providers reference the regulatory distinction between FDA-approved brand-name products and compounded alternatives.
Why this matters
The source for Hers emphasizes FDA-approved brand-name GLP-1s, no compounded medications, and that compounded medications are not FDA-reviewed. TMates stresses that its compounded semaglutide uses the same active ingredient as Ozempic and Wegovy but is compounded and therefore not an FDA-approved finished product.
Price structure and membership
Pricing is a core contrast. Hers lists Wegovy® pill from $149/mo and injectables from $199/mo, and clarifies an active Hers Weight Loss Membership is required ($39 first month, auto-renews at $149/month thereafter) with membership and medication billed separately. TMates offers a flat $199/month at every dose with no step-up fees as dosage escalates and lists various multi-month tiers in captured landing-page evidence.
Review Hers membership and pricing details
Clinical support and access
TMates promotes 24/7 access to U.S.-based doctors and licensed coverage in all 50 states, with virtual check-ins and physician availability beyond messaging-only support. Hers describes a personalized care team with ongoing dose check-ins but notes treatment is available only when a licensed clinician determines it is medically appropriate and that availability is not in all 50 states.
Explore TMates’ 24/7 doctor access
Dosing flexibility, brands, and availability
Hers offers FDA-approved Wegovy® and references brand options like Wegovy® and Zepbound® as FDA-approved for weight loss, while acknowledging Ozempic® is FDA-approved for type 2 diabetes and may be prescribed off-label at a clinician’s discretion. TMates positions compounded semaglutide as offering more flexibility in dosage and access at a lower price point relative to brand-name options, and states it ships to most states with availability based on medical eligibility.
Supported comparison table
| Criteria | Hers | TMates |
|---|---|---|
| Starting price | Wegovy® pill from $149/mo; injectables from $199/mo | $199/month flat, same price at every dose |
| Medication type | FDA-approved Wegovy®, not compounded | Compounded semaglutide formulated in U.S. facilities |
| Regulatory note | No compounded medications; FDA-approved brand-name | Compounded meds are not FDA-approved and not reviewed by FDA |
| Doctor access | Personalized care team with ongoing dose check-ins | 24/7 U.S. doctor access and virtual check-ins |
| State availability | Not available in all 50 states | Licensed coverage in all 50 states |
| Membership | Active membership required; fees noted | Direct-pay flat pricing; free shipping noted |
View TMates’ flat-rate semaglutide program
Patient experience and program notes
Hers emphasizes name-brand medication with no price markups and a personalized care team. It also states medication is not available without an active membership and that a prescription is not guaranteed. TMates highlights a dependable full-service model, consistent physician availability, free shipping, and that compounded semaglutide gives more dosage flexibility.
Conclusion: choosing between Hers and TMates
Hers vs TMates presents a clear tradeoff: Hers for FDA-approved Wegovy® and avoidance of compounded medications; TMates for a predictable flat $199/month compounded semaglutide plan with 24/7 U.S. doctor access and broader stated state coverage.
Choose Hers if you want FDA-approved Wegovy® brand-name semaglutide, prefer not to use compounded medications, and accept membership requirements and state-based availability limitations.
Choose TMates if you prefer a flat $199/month price at every dose, need 24/7 access to U.S.-based doctors, and are comfortable with compounded semaglutide formulated in U.S. facilities.